학술논문
Maintenance olaparib plus bevacizumab in patients with newly diagnosed advanced high-grade ovarian cancer: Main analysis of second progression-free survival in the phase III PAOLA-1/ENGOT-ov25 trial
Document Type
Article
Author
González-Martín, A.; Desauw, C.; Heitz, F.; Cropet, C.; Gargiulo, P.; Berger, R.; Ochi, H.; Vergote, I.; Colombo, N.; Mirza, M.R.; Tazi, Y.; Canzler, U.; Zamagni, C.; Guerra-Alia, E.M.; Levaché, C.B.; Marmé, F.; Bazan, F.; de Gregorio, N.; Dohollou, N.; Fasching, P.A.; Scambia, G.; Rubio-Pérez, M.J.; Milenkova, T.; Costan, C.; Pautier, P.; Ray-Coquard, I.
Source
In: European Journal of Cancer . (European Journal of Cancer, October 2022, 174:221-231)
Subject
Language
English
ISSN
18790852
09598049
09598049